Romosozumab for the treatment of osteoporosis

Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial

Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889 · see citing works

Osteoporosis Prevention, Diagnosis, and Therapy

NIH Consensus Development Panel on Osteoporosis Prevention, D. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.6.785 · Cited by 5,529 · see citing works

Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis

Neer, R. M., Arnaud, C. D., Zanchetta, J. R., Prince, R., Gaich, G. A., Reginster, J.-Y., Hodsman, A. B., Eriksen, E. F., Ish-Shalom, S., Genant, H. K., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105103441904 · Cited by 4,602 · see citing works

Clinician’s Guide to Prevention and Treatment of Osteoporosis

Cosman, F., de Beur, S. J., LeBoff, M. S., Lewiecki, E. M., Tanner, B., Randall, S., & Lindsay, R. (2014) · Osteoporosis International · doi:10.1007/s00198-014-2794-2 · Cited by 4,149 · see citing works

The diagnosis of osteoporosis

Professor Kanis, J. A., Melton, L. J., Christiansen, C., Johnston, C. C., & Khaltaev, N. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650090802 · Cited by 3,849 · see citing works

Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis

Black, D. M., Delmas, P. D., Eastell, R., Reid, I. R., Boonen, S., Cauley, J. A., Cosman, F., Lakatos, P., Leung, P. C., Man, Z., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067312 · Cited by 2,986 · see citing works

European guidance for the diagnosis and management of osteoporosis in postmenopausal women

Kanis, J. A., McCloskey, E. V., Johansson, H., Cooper, C. C., Rizzoli, R., & Reginster, J. (2012) · Osteoporosis International · doi:10.1007/s00198-012-2074-y · Cited by 2,954 · see citing works

Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women With Postmenopausal Osteoporosis<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

Harris, S. T. (1999) · JAMA · doi:10.1001/jama.282.14.1344 · Cited by 2,475 · see citing works

Atypical subtrochanteric and diaphyseal femoral fractures: Second report of a task force of the American Society for Bone and Mineral Research

Shane, E., Burr, D., Abrahamsen, B., Adler, R. A., Brown, T. D., Cheung, A. M., Cosman, F., Curtis, J. R., Dell, R., Dempster, D. W., et al. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1998 · Cited by 2,147 · see citing works

WNT signaling in bone homeostasis and disease: From human mutations to treatments

Baron, R., & Kneissel, M. (2013) · Nature Medicine · doi:10.1038/nm.3074 · Cited by 2,093 · see citing works

WNT signalling pathways as therapeutic targets in cancer

Anastas, J. N., & Moon, R. T. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3419 · Cited by 1,902 · see citing works

Romosozumab Treatment in Postmenopausal Women with Osteoporosis

Cosman, F., Crittenden, D. B., Adachi, J. D., Binkley, N., Czerwinski, E., Ferrari, S., Hofbauer, L. C., Lau, E., Lewiecki, E. M., Miyauchi, A., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1607948 · Cited by 1,805 · see citing works

The Recent Prevalence of Osteoporosis and Low Bone Mass in the United States Based on Bone Mineral Density at the Femoral Neck or Lumbar Spine

Wright, N. C., Looker, A. C., Saag, K. G., Curtis, J. R., Delzell, E. S., Randall, S., & Dawson-Hughes, B. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2269 · Cited by 1,801 · see citing works

Canonical wnt signaling in differentiated osteoblasts controls osteoclast differentiation.

Glass, D. A., Bialek, P., Ahn, J. D., Starbuck, M., Patel, M. S., Clevers, H., Taketo, M. M., Long, F., McMahon, A. P., Lang, R. A., et al. (2005) · Developmental Cell · doi:10.1016/j.devcel.2005.02.017 · Cited by 1,558 · see citing works

A systematic review of hip fracture incidence and probability of fracture worldwide

Kanis, J. A., Odén, A., McCloskey, E. V., Johansson, H., Wahl, D. A., Cooper, C. C., & on behalf of the IOF Working Group on Epidemiology and Quality of Life (2012) · Osteoporosis International · doi:10.1007/s00198-012-1964-3 · Cited by 1,382 · see citing works

Prevalence of low femoral bone density in older U.S. women from NHANES III

Looker, A. C., Johnston, C. C., Wahner, H. W., Dunn, W. L., Calvo, M. S., Harris, T. B., Heyse, S. P., & Lindsay, R. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650100517 · Cited by 1,379 · see citing works

Romosozumab in Postmenopausal Women with Low Bone Mineral Density

McClung, M. R., Grauer, A., Boonen, S., Bolognese, M. A., Brown, J. P., Diez-Perez, A., Langdahl, B. L., Reginster, J.-Y., Zanchetta, J. R., Wasserman, S. M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1305224 · Cited by 1,258 · see citing works

Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)

Balemans, W. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.5.537 · Cited by 1,147 · see citing works

American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis — 2016--Executive Summary

Camacho, P. M., Petak, S. M., Binkley, N., Clarke, B. L., Harris, S. T., Hurley, D. L., Kleerekoper, M., Lewiecki, E. M., Miller, P. D., Narula, H. S., et al. (2016) · Endocrine Practice · doi:10.4158/ep161435.esgl · Cited by 1,140 · see citing works

Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research

Shane, E., Burr, D., Ebeling, P. R., Abrahamsen, B., Adler, R. A., Brown, T. D., Cheung, A. M., Cosman, F., Curtis, J. R., Dell, R., et al. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.253 · Cited by 1,116 · see citing works

Prevalence of Low Femoral Bone Density in Older U.S. Adults from NHANES III

Looker, A. C., ORWOLL, E. S., Johnston, C. C., Lindsay, R., Wahner, H. W., Dunn, W. L., Calvo, M. S., Harris, T. B., & Heyse, S. P. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.11.1761 · Cited by 1,052 · see citing works

Bone Dysplasia Sclerosteosis Results from Loss of the SOST Gene Product, a Novel Cystine Knot–Containing Protein

Brunkow, M. E., Gardner, J. C., Van Ness, J., Paeper, B. W., Kovacevich, B. R., Proll, S., Skonier, J. E., Zhao, L., Sabo, P. J., Fu, Y.-H., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/318811 · Cited by 1,011 · see citing works

Targeted Deletion of the Sclerostin Gene in Mice Results in Increased Bone Formation and Bone Strength

Li, X., Ominsky, M. S., Niu, Q., Sun, N., Daugherty, B., D’Agostin, D. M., Kurahara, C., Gao, Y., Cao, J., Gong, J., et al. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080216 · Cited by 938 · see citing works

Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody

Padhi, D., Jang, G. R., Stouch, B., Fang, L., & Posvar, E. L. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.173 · Cited by 786 · see citing works

Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis

Li, X., Ominsky, M. S., Warmington, K. S., Morony, S., Gong, J., Cao, J., Gao, Y., Shalhoub, V., Tipton, B., Haldankar, R., et al. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.081206 · Cited by 784 · see citing works

Identification of a 52 kb deletion downstream of the <i>SOST</i> gene in patients with van Buchem disease

Balemans, W., Patel, N., Ebeling, M., Van Hul, E., Wuyts, W., Lacza, C., Dioszegi, M., Dikkers, F. G., Hildering, P., Willems, P. J., et al. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.2.91 · Cited by 698 · see citing works

Skeletal Changes in Rats Given Daily Subcutaneous Injections of Recombinant Human Parathyroid Hormone (1-34) for 2 Years and Relevance to Human Safety

Vahle, J. L., Sato, M., Long, G. G., Young, J. K., Francis, P. C., Engelhardt, J. A., Westmore, M. S., Ma, Y. L., & Nold, J. B. (2002) · Toxicologic Pathology · doi:10.1080/01926230252929882 · Cited by 694 · see citing works

Mechanisms of Anabolic Therapies for Osteoporosis

CANALIS, E. M., Giustina, A., & Bilezikian, J. P. (2007) · New England Journal of Medicine · doi:10.1056/nejmra067395 · Cited by 666 · see citing works

SOST is a target gene for PTH in bone

Keller, H., & Kneissel, M. (2005) · Bone · doi:10.1016/j.bone.2005.03.018 · Cited by 618 · see citing works

Multinational, Placebo-Controlled, Randomized Trial of the Effects of Alendronate on Bone Density and Fracture Risk in Postmenopausal Women with Low Bone Mass: Results of the FOSIT Study

Pols, H. A. P., Felsenberg, D., Hanley, D. A., Stepan, J. J., Muñoz‐Torres, M., Wilkin, T. J., Ge, Q.-S., Galich, A. M., Vandormael, K., Yates, A. J. P., et al. (1999) · Osteoporosis International · doi:10.1007/pl00004171 · Cited by 586 · see citing works

American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis — 2016

Camacho, P. M., Petak, S. M., Binkley, N., Clarke, B. L., Harris, S. T., Hurley, D. L., Kleerekoper, M., Lewiecki, E. M., Miller, P. D., Narula, H. S., et al. (2016) · Endocrine Practice · doi:10.4158/ep161435.gl · Cited by 487 · see citing works

Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength

Ominsky, M. S., Vlasseros, F., Jolette, J., Smith, S. Y., Stouch, B., Doellgast, G. J., Gong, J., Gao, Y., Cao, J., Graham, K. C., et al. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.14 · Cited by 414 · see citing works

Three decades of Wnts: a personal perspective on how a scientific field developed

Nusse, R., & VARMUS, H. E. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.146 · Cited by 412 · see citing works

Osteoporosis Medication Use After Hip Fracture in U.S. Patients Between 2002 and 2011

Solomon, D. H., Johnston, S. S., Boytsov, N. N., McMorrow, D., Lane, J. M., & Krohn, K. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2202 · Cited by 366 · see citing works

Bone Remodeling Increases Substantially in the Years After Menopause and Remains Increased in Older Osteoporosis Patients

Recker, R. R., Lappe, J. M., Davies, K. M., & Heaney, R. P. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040710 · Cited by 342 · see citing works

Wnt signalling in osteoblasts regulates expression of the receptor activator of NFκB ligand and inhibits osteoclastogenesis in vitro

Spencer, G. J., Utting, J. C., Etheridge, S. L., Arnett, T. R., & Genever, P. G. (2006) · Journal of Cell Science · doi:10.1242/jcs.02883 · Cited by 334 · see citing works

The US postmarketing surveillance study of adult osteosarcoma and teriparatide: Study design and findings from the first 7 years

Andrews, E. B., Gilsenan, A., Midkiff, K. D., Sherrill, B. H., Wu, Y., Mann, B. H., & Masica, D. N. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1768 · Cited by 272 · see citing works

Bone Modeling and Remodeling

Seeman, E. (2009) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v19.i3.40 · Cited by 242 · see citing works

Characterization of the Structural Features and Interactions of Sclerostin

Veverka, V., Henry, A. J., Slocombe, P. M., Ventom, A. M., Mulloy, B., Muskett, F. W., Muzylak, M., Greenslade, K. J., Moore, A., Zhang, L., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807994200 · Cited by 236 · see citing works

Involvement of WNT/β-catenin Signaling in the Treatment of Osteoporosis

Rossini, M., Gatti, D., & Adami, S. (2013) · Calcified Tissue International · doi:10.1007/s00223-013-9749-z · Cited by 236 · see citing works

Inhibition of sclerostin by monoclonal antibody increases bone formation, bone mass, and bone strength in aged male rats

Li, X., Warmington, K. S., Niu, Q., Asuncion, F., Barrero, M., Grisanti, M. S., Dwyer, D., Stouch, B., Thway, T. M., Stolina, M., et al. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.182 · Cited by 231 · see citing works

Teriparatide for osteoporosis: importance of the full course

Lindsay, R., Krege, J. H., Marín, F. R., Jin, L., & Stepan, J. J. (2016) · Osteoporosis International · doi:10.1007/s00198-016-3534-6 · Cited by 204 · see citing works

Multiple doses of sclerostin antibody romosozumab in healthy men and postmenopausal women with low bone mass: A randomized, double-blind, placebo-controlled study

Padhi, D., Allison, M. J., Kivitz, A., Gutierrez, M. J., Stouch, B., Wang, C., & Jang, G. R. (2013) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.239 · Cited by 185 · see citing works

Biphasic and Dosage-Dependent Regulation of Osteoclastogenesis by β-Catenin

Wei, W., Zeve, D., Suh, J. M., Wang, X., Du, Y., Zerwekh, J. E., Dechow, P. C., Graff, J. M., & Wan, Y. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05980-11 · Cited by 181 · see citing works

Sclerostin antibody increases bone mass by stimulating bone formation and inhibiting bone resorption in a hindlimb-immobilization rat model

Tian, X., Jee, W. S. S., Li, X., Pászty, C., & Ke, H. Z. (2010) · Bone · doi:10.1016/j.bone.2010.09.009 · Cited by 178 · see citing works

Bone Mineral Density in Sclerosteosis; Affected Individuals and Gene Carriers

Gardner, J. C., van Bezooijen, R. L., Mervis, B., Hamdy, N. A. T., Löwik, C. W. G. M., Hamersma, H. A., Beighton, P., & Papapoulos, S. E. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1235 · Cited by 176 · see citing works

An uncommon familial systemic disease of the skeleton: Hyperostosis corticalis generalisata familiaris

van Buchem, F. S. P., Hadders, H. N., & Ubbens, R. (1955) · Acta Radiologica · doi:10.3109/00016925509170789 · Cited by 148 · see citing works

Effects of Romosozumab Compared With Teriparatide on Bone Density and Mass at the Spine and Hip in Postmenopausal Women With Low Bone Mass

Genant, H. K., Engelke, K., Bolognese, M. A., Mautalén, C., Brown, J. P., Recknor, C. P., Goemaere, S., Fuerst, T. P., Yang, Y., Grauer, A., et al. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2932 · Cited by 143 · see citing works

Sclerostin antibody treatment enhances metaphyseal bone healing in rats

Agholme, F., Li, X., Isaksson, H., Ke, H. Z., & Aspenberg, P. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.135 · Cited by 142 · see citing works

Trends in osteoporosis treatment with oral and intravenous bisphosphonates in the United States, 2002–2012

Wysowski, D. K., & Greene, P. (2013) · Bone · doi:10.1016/j.bone.2013.09.008 · Cited by 138 · see citing works

Patients with sclerosteosis and disease carriers: Human models of the effect of sclerostin on bone turnover

van Lierop, A. H., Hamdy, N. A. T., Hamersma, H. A., van Bezooijen, R. L., Power, J., Loveridge, N., & Papapoulos, S. E. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.474 · Cited by 133 · see citing works

A novel strategy for generating monoclonal antibodies from single, isolated lymphocytes producing antibodies of defined specificities.

Babcook, J. S., Leslie, K. B., Olsen, O. A., Salmon, R. A., & Schrader, J. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7843 · Cited by 132 · see citing works

The use of parathyroid hormone in the treatment of osteoporosis

Girotra, M., Rubin, M. R., & Bilezikian, J. P. (2006) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-006-9007-z · Cited by 125 · see citing works

Incidence of hip fracture in Brazil and the development of a FRAX model

Zerbini, C. A. F., Szejnfeld, V. L., Abergaria, B. H., McCloskey, E. V., Johansson, H., & Kanis, J. A. (2015) · Archives of Osteoporosis · doi:10.1007/s11657-015-0224-5 · Cited by 114 · see citing works

A review on strontium ranelate long-term antifracture efficacy in the treatment of postmenopausal osteoporosis

Cianferotti, L., D’Asta, F., & Brandi, M. L. (2013) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x13483187 · Cited by 111 · see citing works

Latitude, socioeconomic prosperity, mobile phones and hip fracture risk

Johnell, O., Borgström, F., Jönsson, B., & Kanis, J. A. (2006) · Osteoporosis International · doi:10.1007/s00198-006-0245-4 · Cited by 107 · see citing works

Romosozumab Improves Bone Mass and Strength While Maintaining Bone Quality in Ovariectomized Cynomolgus Monkeys

Ominsky, M. S., Boyd, S. K., Varela, A., Jolette, J., Felx, M., Doyle, N. E., Mellal, N., Smith, S. Y., Locher, K., Buntich, S., et al. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3036 · Cited by 104 · see citing works

Patients with Van Buchem Disease, an Osteosclerotic Genetic Disease, Have Elevated Bone Formation Markers, Higher Bone Density, and Greater Derived Polar Moment of Inertia than Normal

Wergedal, J. E., Veskovic, K., Hellan, M., Nyght, C., Balemans, W., Libanati, C. R., Vanhoenacker, F. M. H. M., Tan, J., Baylink, D. J., & Hul, W. V. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030201 · Cited by 98 · see citing works

A Short Treatment With an Antibody to Sclerostin Can Inhibit Bone Loss in an Ongoing Model of Colitis

Eddleston, A., Marenzana, M., Moore, A., Stephens, P. E., Muzylak, M., Marshall, D., & Robinson, M. K. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090403 · Cited by 98 · see citing works

Sclerosteosis

Stein, S. A., Witkop, C. J., Hill, S. C., Fallon, M. D., Viernstein, L. J., Gucer, G., McKeever, P. E., Long, D. M., Altman, J., Miller, N. R., et al. (1983) · Neurology · doi:10.1212/wnl.33.3.267 · Cited by 96 · see citing works

Increased Bone Formation and Bone Mass Induced by Sclerostin Antibody Is Not Affected by Pretreatment or Cotreatment with Alendronate in Osteopenic, Ovariectomized Rats

Li, X., Ominsky, M. S., Warmington, K. S., Niu, Q., Asuncion, F., Barrero, M., Dwyer, D., Grisanti, M. S., Stolina, M., Kostenuik, P. J., et al. (2011) · Endocrinology · doi:10.1210/en.2011-0252 · Cited by 87 · see citing works

Carcinogenicity risk assessment of romosozumab: A review of scientific weight-of-evidence and findings in a rat lifetime pharmacology study

Chouinard, L., Felx, M., Mellal, N., Varela, A., Mann, P., Jolette, J., Samadfam, R., Smith, S. Y., Locher, K., Buntich, S., et al. (2016) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2016.08.010 · Cited by 84 · see citing works

Administration of romosozumab improves vertebral trabecular and cortical bone as assessed with quantitative computed tomography and finite element analysis

Graeff, C., Campbell, G. M., Peña, J. A., Borggrefe, J., Padhi, D., Kaufman, A., Chang, S., Libanati, C. R., & Glüer, C. (2015) · Bone · doi:10.1016/j.bone.2015.07.036 · Cited by 79 · see citing works

Increased callus mass and enhanced strength during fracture healing in mice lacking the sclerostin gene

Li, C., Ominsky, M. S., Tan, H., Barrero, M., Niu, Q., Asuncion, F., Lee, E. W., Liu, M., Simonet, W. S., Pászty, C., et al. (2011) · Bone · doi:10.1016/j.bone.2011.08.012 · Cited by 73 · see citing works

Sclerostin antibody treatment enhances bone strength but does not prevent growth retardation in young mice treated with dexamethasone

Marenzana, M., Greenslade, K. J., Eddleston, A., Okoye, R., Marshall, D. R., Moore, A., & Robinson, M. K. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30385 · Cited by 73 · see citing works

Osteopetrosis with syndactyly; a morphological variant of Albers-Schönberg's disease.

As, T. (1958) · PubMed · Cited by 71 · see citing works

Sclerostin: Therapeutic Horizons Based Upon Its Actions

Costa, A. G., & Bilezikian, J. P. (2012) · Current Osteoporosis Reports · doi:10.1007/s11914-011-0089-5 · Cited by 70 · see citing works

Anabolic effects of PTH and the ‘anabolic window’

Pazianas, M. (2015) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2015.01.004 · Cited by 31 · see citing works

Emerging Therapies for Osteoporosis

McClung, M. R. (2015) · Endocrinology and Metabolism · doi:10.3803/enm.2015.30.4.429 · Cited by 30 · see citing works

New insights into treatment of osteoporosis in postmenopausal women

Geusens, P. (2015) · RMD Open · doi:10.1136/rmdopen-2015-000051 · Cited by 26 · see citing works

Meta‐analysis about efficacy of anti‐resorptive drugs in post‐menopausal osteoporosis

de Macedo, J. M. S., Macedo, C. R. B., Elkis, H., & Oliveira, I. R. D. (1998) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.1365-2710.1998.00168.x · Cited by 25 · see citing works

Analyses of bone modeling and remodeling using in vitro reconstitution system with two-photon microscopy

Hikita, A., Iimura, T., Oshima, Y., Saitou, T., Yamamoto, S., & Imamura, T. (2015) · Bone · doi:10.1016/j.bone.2015.02.030 · Cited by 20 · see citing works

Acting on black box warnings requires a GRADE evidence table and an implementation guide: the case of teriparatide

Elraiyah, T. A., Gionfriddo, M. R., & Murad, M. H. (2015) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2015.01.025 · Cited by 13 · see citing works

Biphasic and dosage-dependent regulation of osteoclastogenesis by beta-catenin

Wan, Y., Wei, W., Zeve, D., Suh, J. M., Wang, X., Du, Y., Zerwekh, J. E., Dechow, P. C., & Graff, J. M. (2011) · Bone · doi:10.1016/j.bone.2011.03.353 · Cited by 9 · see citing works

Superior Gains in Bone Mineral Density (BMD) and Estimated Strength at the Hip for Romosozumab Compared With Teriparatide (TPTD) in Women With Postmenopausal Osteoporosis Transitioning From Bisphosphonate Therapy: Results of the Phase 3 Open-label STRUCTURE Study

Langdahl, B. L., Libanati, C. R., Crittenden, D. B., Bolognese, M. A., Brown, J. P., Daizadeh, N. S., Dokoupilová, E., Engelke, K., Finkelstein, J. S., Genant, H. K., et al. (2016) · Bone Abstracts · doi:10.1530/boneabs.5.ht5 · Cited by 7 · see citing works

Osteoporosis in Older Adults

Johnston, C. B., & Dagar, M. (2020) · Medical Clinics of North America · doi:10.1016/j.mcna.2020.06.004 · Cited by 634 · see citing works

Osteoporosis pathogenesis and treatment: existing and emerging avenues

Liang, B., Burley, G., Lin, S., & Shi, Y. (2022) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-022-00371-3 · Cited by 250 · see citing works

Osteoporosis: Mechanism, Molecular Target and Current Status on Drug Development

Li, H., Xiao, Z., Quarles, L. D., & Li, W. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867327666200330142432 · Cited by 226 · see citing works

Osteoporosis in patients with chronic kidney diseases: A systemic review

Hsu, C.-Y., Chen, L.-R., & Chen, K.-H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186846 · Cited by 162 · see citing works

Insights and implications of sexual dimorphism in osteoporosis

Zhang, Y., Xie, N., Sun, X., Nice, E. C., Liou, Y., Huang, C., Zhu, H., & Shen, Z. (2024) · Bone Research · doi:10.1038/s41413-023-00306-4 · Cited by 160 · see citing works

Regulation of bone homeostasis: signaling pathways and therapeutic targets

Wu, Z., Li, W., Jiang, K., Lin, Z., Qian, C., Wu, M., Xia, Y., Li, N., Zhang, H., Xiao, H.-X., et al. (2024) · MedComm · doi:10.1002/mco2.657 · Cited by 115 · see citing works

Ovariectomy Activates Chronic Low-Grade Inflammation Mediated by Memory T Cells, Which Promotes Osteoporosis in Mice

Cline-Smith, A., Axelbaum, A., Shashkova, E., Chakraborty, M., Sanford, J., Panesar, P., Peterson, M., Cox, L., Baldan, A., Veis, D., et al. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3966 · Cited by 108 · see citing works

The prevention of osteoporosis and sarcopenia in older adults

Coll, P. P., Phu, S., Hajjar, S. H., Kirk, B., Duque, G., & Taxel, P. (2021) · Journal of the American Geriatrics Society · doi:10.1111/jgs.17043 · Cited by 101 · see citing works

Osteoporosis, bone mineral density and CKD–MBD: treatment considerations

Bover, J., Bailone, L., López‐Báez, V., Benito, S., Ciceri, P., Galassi, A., & Cozzolino, M. G. (2017) · Journal of Nephrology · doi:10.1007/s40620-017-0404-z · Cited by 87 · see citing works

Deciphering the Relevance of Bone ECM Signaling

Alcorta-Sevillano, N., Macías, I., Infante, A., & Rodrı́guez, C. I. (2020) · Cells · doi:10.3390/cells9122630 · Cited by 84 · see citing works

Effects of Teriparatide and Vibration on Bone Mass and Bone Strength in People with Bone Loss and Spinal Cord Injury: A Randomized, Controlled Trial

Edwards, W. B., Simonian, N., Haider, I. T., Anschel, A. S., Chen, D., Gordon, K. E., Gregory, E. K., Kim, K. H., Parachuri, R., Troy, K. L., et al. (2018) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3525 · Cited by 69 · see citing works

Anabolic therapy for osteoporosis: update on efficacy and safety

Bandeira, L., & Lewiecki, E. M. (2022) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000566 · Cited by 65 · see citing works

Advances in the occurrence and biotherapy of osteoporosis

Zi, Z., Liu, W. X., Cao, L., Liu, Y., He, T., Peng, S., & Shuai, C. (2020) · Biochemical Society Transactions · doi:10.1042/bst20200005 · Cited by 58 · see citing works

Dietary phlorizin enhances osteoblastogenic bone formation through enhancing β-catenin activity via GSK-3β inhibition in a model of senile osteoporosis

Antika, L. D., Lee, E., Kim, Y., Kang, M., Park, S., Kim, D. Y., Oh, H., Choi, Y. J., & Kang, Y. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.07.014 · Cited by 56 · see citing works

Osteoclasts and Microgravity

Smith, J. K. (2020) · Life · doi:10.3390/life10090207 · Cited by 52 · see citing works

Early clinical effects, safety, and predictors of the effects of romosozumab treatment in osteoporosis patients: one-year study

Tominaga, A., Wada, K., Okazaki, K., Nishi, H., Terayama, Y., & Kato, Y. (2021) · Osteoporosis International · doi:10.1007/s00198-021-05925-3 · Cited by 50 · see citing works

Romosozumab: A Novel Agent in the Treatment for Postmenopausal Osteoporosis

Miller, S. A., St. Onge, E. L., & Whalen, K. L. (2021) · Journal of Pharmacy Technology · doi:10.1177/8755122520967632 · Cited by 46 · see citing works

Learning from Monocyte-Macrophage Fusion and Multinucleation: Potential Therapeutic Targets for Osteoporosis and Rheumatoid Arthritis

Gambari, L., Grassi, F., Roseti, L., Grigolo, B., & Desando, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176001 · Cited by 45 · see citing works

Comprehensive circular RNA profiling reveals circ_0002060 as a potential diagnostic biomarkers for osteoporosis

Huang, Y.-P., Xie, J., & Li, E. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28838 · Cited by 44 · see citing works

Targeting SOST using a small-molecule compound retards breast cancer bone metastasis

Sun, L., Zhang, Y., Chen, G., Ji, Y., Ma, Q., Qiao, X., Wu, S., Zhou, L. M., Bu, J., Zhu, X., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01697-4 · Cited by 40 · see citing works

Disparate bone anabolic cues activate bone formation by regulating the rapid lysosomal degradation of sclerostin protein

Gould, N. R., Williams, K. M., Joca, H. C., Torre, O. M., Lyons, J. S., Leser, J. M., Srikanth, M. P., Hughes, M., Khairallah, R. J., Feldman, R. A., et al. (2021) · eLife · doi:10.7554/elife.64393 · Cited by 40 · see citing works

Secreted Frizzled‐related proteins (sFRPs) in osteo‐articular diseases: much more than simple antagonists of Wnt signaling?

Claudel, M., Jouzeau, J., & Cailotto, F. (2019) · FEBS Journal · doi:10.1111/febs.15119 · Cited by 39 · see citing works

Aberrant BMP2 Signaling in Patients Diagnosed with Osteoporosis

Durbano, H. W., Halloran, D. R., Nguyen, J., Stone, V., McTague, S., Eskander, M. S., & Nohe, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186909 · Cited by 38 · see citing works

Nobiletin-loaded micelles reduce ovariectomy-induced bone loss by suppressing osteoclastogenesis

Wang, Y., Xie, J. W., Ai, Z., & Su, J. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s213724 · Cited by 36 · see citing works

CircRNA_0001795 sponges miRNA-339-5p to regulate yes-associated protein 1 expression and attenuate osteoporosis progression

Li, M.-Y., Li, C., Zheng, H., Zhou, Z., Yang, W., Gong, Y., Wu, X., & Li, L.-Y. (2022) · Bioengineered · doi:10.1080/21655979.2021.2022074 · Cited by 27 · see citing works

Evaluation and Management of Osteoporosis and Sarcopenia in Patients with Distal Radius Fractures

Shah, G. M., Gong, H. S., Chae, Y. J., Kim, Y. S., Kim, J., & Baek, G. H. (2020) · Clinics in Orthopedic Surgery · doi:10.4055/cios.2020.12.1.9 · Cited by 35 · see citing works

Orthodontic retention: what's on the horizon?

Littlewood, S., Dalci, O., Dolce, C., Holliday, L. S., & Naraghi, S. (2021) · BDJ · doi:10.1038/s41415-021-2937-8 · Cited by 36 · see citing works

Sphingosine‐1‐phosphate (S1P) receptors: Promising drug targets for treating bone‐related diseases

Zhang, L., Dong, Y., Wang, Y., Hu, W., Dong, S., & Chen, Y. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15155 · Cited by 33 · see citing works

Effect of the duration of previous osteoporosis treatment on the effect of romosozumab treatment

Tominaga, A., Wada, K., Okazaki, K., Nishi, H., Terayama, Y., Kodama, Y., & Kato, Y. (2022) · Osteoporosis International · doi:10.1007/s00198-021-06261-2 · Cited by 32 · see citing works

Osteoporosis in Inflammatory Arthritides: New Perspective on Pathogenesis and Treatment

Rotta, D., Fassio, A., Rossini, M., Giollo, A., Viapiana, O., Orsolini, G., Bertoldo, E., Gatti, D., & Adami, G. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.613720 · Cited by 29 · see citing works

The pathophysiology of immunoporosis: innovative therapeutic targets

Ferbebouh, M., Vallières, F., Benderdour, M., & Fernandes, J. (2021) · Inflammation Research · doi:10.1007/s00011-021-01484-9 · Cited by 31 · see citing works

Circ‐SLC8A1 regulates osteoporosis through blocking the inhibitory effect of miR‐516b‐5p on AKAP2 expression

Lin, C., Zhong, W., Yan, W., Yang, J., Zheng, W., & Wu, Q. (2020) · Journal of Gene Medicine · doi:10.1002/jgm.3263 · Cited by 22 · see citing works

Efficacy of romosozumab for osteoporosis in a patient with osteogenesis imperfecta: A case report

Uehara, M., Nakamura, Y., Nakano, M., Miyazaki, A., Suzuki, T., & Takahashi, J. (2021) · Modern Rheumatology Case Reports · doi:10.1093/mrcr/rxab018 · Cited by 25 · see citing works

Medical optimization of osteoporosis for adult spinal deformity surgery: a state-of-the-art evidence-based review of current pharmacotherapy

Zhang, A. S., Khatri, S., Balmaceno-Criss, M., Alsoof, D., & Daniels, A. H. (2022) · Spine Deformity · doi:10.1007/s43390-022-00621-6 · Cited by 23 · see citing works

Increased Serum Sclerostin Levels in Patients With Active Acromegaly

Pekkolay, Z., Kılınç, F., Gözel, N., Etem, E. Ö., & Tuzcu, A. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz254 · Cited by 23 · see citing works

Early clinical effects, safety, and appropriate selection of bone markers in romosozumab treatment for osteoporosis patients: a 6-month study

Tominaga, A., Wada, K., Kato, Y., Nishi, H., Terayama, Y., & Okazaki, K. (2020) · Osteoporosis International · doi:10.1007/s00198-020-05639-y · Cited by 22 · see citing works

Cyclooxygenase-2/sclerostin mediates TGF-β1-induced calcification in vascular smooth muscle cells and rats undergoing renal failure

He, F., Li, L., Li, P., Deng, Y., Yang, Y., Deng, Y., Luo, H., Yao, X., Su, Y., Gan, H., et al. (2020) · Aging · doi:10.18632/aging.103827 · Cited by 20 · see citing works

Open-label clinical trial of alendronate after teriparatide therapy in people with spinal cord injury and low bone mineral density

Haider, I. T., Simonian, N., Saini, A. S., Leung, F. M., Edwards, W. B., & Schnitzer, T. J. (2019) · Spinal Cord · doi:10.1038/s41393-019-0303-3 · Cited by 20 · see citing works

Oral Administration of Isovitexin, a Naturally Occurring Apigenin Derivative Showed Osteoanabolic Effect in Ovariectomized Mice: A Comparative Study with Teriparatide

Pal, S., Sharma, S., Porwal, K., Riyazuddin, M., Kulkarni, C., Chattopadhyay, S., Sanyal, S., Gayen, J. R., & Chattopadhyay, N. (2022) · Calcified Tissue International · doi:10.1007/s00223-022-00979-9 · Cited by 19 · see citing works

Examining the role of cannabinoids on osteoporosis: a review

Clouse, G., Penman, S. L., Hadjiargyrou, M., Komatsu, D. E., & Thanos, P. K. (2022) · Archives of Osteoporosis · doi:10.1007/s11657-022-01190-x · Cited by 19 · see citing works

Loss of Nmp4 optimizes osteogenic metabolism and secretion to enhance bone quality

Shao, Y., Zielinski, E., Childress, P., Adaway, M., Misra, J., Klunk, A. J., Burr, D. B., Wek, R. C., Mosley, A. L., Liu, Y., et al. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00343.2018 · Cited by 19 · see citing works

Sclerostin: clinical insights in muscle–bone crosstalk

Moretti, A., & Iolascon, G. (2023) · Journal of International Medical Research · doi:10.1177/03000605231193293 · Cited by 17 · see citing works

Leonurine hydrochloride promotes osteogenic differentiation and increases osteoblastic bone formation in ovariectomized mice by Wnt/β-catenin pathway

Yang, L., Liu, S., Mu, S., Man, X., Ba, G., Guo, R., Li, Y., Zhou, L., Yang, L., & Fu, Q. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.09.008 · Cited by 17 · see citing works

BMP delivery systems for bone regeneration: Healthy vs osteoporotic population. Review

Segredo-Morales, E., García‐García, P., Évora, C., & Delgado, A. (2017) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2017.05.014 · Cited by 17 · see citing works

Monitoring and maintaining bone health in patients with Turner syndrome

Chiarito, M., Brunetti, G., D’Amato, G., & Faienza, M. F. (2020) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2020.1834846 · Cited by 15 · see citing works

Carfilzomib alleviated osteoporosis by targeting PSME1/2 to activate Wnt/β-catenin signaling

Zhang, F., Attarilar, S., Xie, K., Han, C., Liang, Q., Huang, K., Lan, C., Wang, C., Yang, C., Wang, L., et al. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111520 · Cited by 15 · see citing works

Prevention of Osteoporotic Fractures in Residential Aged Care: Updated Consensus Recommendations

Duque, G., Iuliano, S., Close, J., Fatima, M., Ganda, K., Bird, S., Kirk, B., Levidiotis, M. L., Said, C. M., Παπαϊωάννου, Α., et al. (2022) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2021.12.041 · Cited by 15 · see citing works

Clinical Characteristics and Controllable Risk Factors of Osteoporosis in Elderly Men with Diabetes Mellitus

Li, C., Wang, S., Du, M.-R., Wei, Y., & Jiang, S. (2021) · Orthopaedic Surgery · doi:10.1111/os.12957 · Cited by 13 · see citing works

Does Aging Activate T-cells to Reduce Bone Mass and Quality?

Aurora, R., & Novack, D. V. (2022) · Current Osteoporosis Reports · doi:10.1007/s11914-022-00745-8 · Cited by 12 · see citing works

Microgravity, Bone Homeostasis, and Insulin-Like Growth Factor-1

Smith, J. K. (2020) · Applied Sciences · doi:10.3390/app10134433 · Cited by 12 · see citing works

The Dietary and Non-Dietary Management of Osteoporosis in Adult-Onset Celiac Disease: Current Status and Practical Guidance

Al-Toma, A. A., Herman, A., Lems, W. F., & Mulder, C. J. J. (2022) · Nutrients · doi:10.3390/nu14214554 · Cited by 12 · see citing works

An update on the pharmacotherapy of osteoporosis

Shashidhara, A., Tahir, S. H., Syed, Z. A., Lee, J., & Tahir, H. (2025) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2025.2489122 · Cited by 11 · see citing works

The miR-187 induced bone reconstruction and healing in a mouse model of osteoporosis, and accelerated osteoblastic differentiation of human multipotent stromal cells by targeting BARX2

Zhang, J., Zhang, T., Tang, B., Li, J., & Zha, Z. (2021) · Pathology - Research and Practice · doi:10.1016/j.prp.2021.153340 · Cited by 10 · see citing works

Novel transplant of combined platelet-rich fibrin Releasate and bone marrow stem cells prevent bone loss in Ovariectomized osteoporotic mice

Wong, C.-C., Liao, J.-H., Sheu, S.-Y., Lin, P.-Y., Chen, C., & Kuo, T. (2020) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-020-03549-y · Cited by 10 · see citing works

Controversies in the treatment of postmenopausal osteoporosis: How long to treat with bisphosphonates?

Bandeira, F., Dantas, W., & Bilezikian, J. P. (2020) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000275 · Cited by 9 · see citing works

Osteoporosis Improved by Romosozumab Therapy in a Patient With Type I Osteogenesis Imperfecta

Dattagupta, A., & Petak, S. M. (2023) · AACE Clinical Case Reports · doi:10.1016/j.aace.2023.10.002 · Cited by 9 · see citing works

Osteoporosis in Adult Patients Undergoing Spinal Reconstructive Surgery: Associated Complications and Management

Sardar, Z. M., Coury, J. R., Polly, D. W., Cheung, K., Lewis, S. J., & Deformity, A. S. K. F. (2025) · Global Spine Journal · doi:10.1177/21925682241289899 · Cited by 8 · see citing works

Discovery of the small molecular inhibitors against sclerostin loop3 as potential anti-osteoporosis agents by structural based virtual screening and molecular design

Yu, S., Huang, W., Zhang, H., Guo, Y., Zhang, B., Zhang, G., & Lei, J. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116414 · Cited by 9 · see citing works

Role of biophysical stimulation in multimodal management of vertebral compression fractures

Martino, A. C. D., Villari, E., Poluzzi, R., Brunello, M., Rossomando, V., D’Agostino, C., Ruta, F., & Faldini, C. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.11.023 · Cited by 7 · see citing works

Aortic carboxypeptidase‐like protein, a putative myokine, stimulates the differentiation and survival of bone‐forming osteoblasts

Kim, H., Kim, M. J., Moon, S. A., Cho, H. J., Lee, Y., Park, S. J., Kim, Y., Baek, I., Kim, B., Lee, S. H., et al. (2023) · The FASEB Journal · doi:10.1096/fj.202300140r · Cited by 6 · see citing works

Nanomaterials‐Based Drug Delivery Systems for Therapeutic Applications in Osteoporosis

Shi, D., Li, Y., Tian, M., Xue, M., Wang, J., & An, H. (2025) · Advanced Biology · doi:10.1002/adbi.202400721 · Cited by 6 · see citing works

Estradiol and RSPO3 regulate vertebral trabecular bone mass independent of each other

Nilsson, K. H., Wu, J., Gustafsson, K. L., Shahawy, M. E., Koskela, A., Tuukkanen, J., Tuckermann, J. P., Henning, P., Lerner, U. H., Ohlsson, C., et al. (2022) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00383.2021 · Cited by 6 · see citing works

Differential bone remodeling mechanism in hindlimb unloaded rats and hibernating Daurian ground squirrels: a comparison between artificial and natural disuse

Gao, X., Wang, S., Zhang, J., Wang, S., Bai, F., Liang, J., Wu, J., Wang, H., Gao, Y., & Chang, H. (2021) · Journal of Comparative Physiology B · doi:10.1007/s00360-021-01375-9 · Cited by 6 · see citing works

Recent advances in biomimetic nanodelivery systems for the treatment of osteoporosis

Ren, Z., Xiao, W., Yang, T., Han, Y., Bai, L., Feng, L., Guo, J., & Liu, S. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102373 · Cited by 6 · see citing works

Small-Molecule Inhibition of SOST Suppresses Breast Cancer Bone Metastasis

Khalil, Y. H., & Nassar, O. S. (2025) · Archive of International Journal of Cancer and Allied Science · doi:10.51847/xr3tpazzri · Cited by 5 · see citing works

A clinician's guide to the management of geriatric musculoskeletal disease: Part 1 - Osteoporosis

Feehan, J., Tripodi, N., Fleischmann, M., Zanker, J., & Duque, G. (2021) · International journal of osteopathic medicine · doi:10.1016/j.ijosm.2021.12.003 · Cited by 5 · see citing works

Eldecalcitol Induces Minimodeling-Based Bone Formation and Inhibits Sclerostin Synthesis Preferentially in the Epiphyses Rather than the Metaphyses of the Long Bones in Rats

Hasegawa, T., Yamamoto, T., Hongo, H., Yamamoto, T., Haraguchi‐Kitakamae, M., Ishizu, H., Shimizu, T., Saitô, H., Sakai, S., Yogo, K., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084257 · Cited by 5 · see citing works

LINC00370 modulates miR-222-3p-RGS4 axis to protect against osteoporosis progression

Li, L., Zheng, B., Zhang, F., Luo, X. Q., Li, F., Xu, T., Zhao, H. C., Shi, G., Guo, Y., Shi, J., et al. (2021) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2021.104505 · Cited by 5 · see citing works

Postmenopausal Osteoporosis

Mesquita, P. N., Maia, J. M. C., Andrade, S. R. D. L., & Bandeira, F. A. F. (2022) · Springer eBooks · doi:10.1007/978-3-030-90684-9_24 · Cited by 5 · see citing works

Clinical challenges and considerations in pharmacotherapy of osteoporosis due to menopause

Palacios, S., Rodríguez, S. P. G., Prieto, M. S., & Fasero, M. (2024) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2024.2383639 · Cited by 4 · see citing works

Osteoporosis management in primary care

Jarrell, L. (2023) · The Nurse Practitioner · doi:10.1097/01.npr.0000000000000090 · Cited by 3 · see citing works

Bone turnover markers

Garnero, P., & Cremers, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814841-9.00078-6 · Cited by 3 · see citing works

The role of anti-osteoporosis drugs in fall risk

Voltan, G., & Veronese, N. (2024) · International Journal of Bone Fragility · doi:10.57582/ijbf.240401.002 · Cited by 3 · see citing works

Deep Learning-Based Self-Efficacy X-Ray Images in the Evaluation of Rheumatoid Arthritis Combined with Osteoporosis Nursing

Geng, Y., Liu, T., Ding, Y., Liu, W., Ye, J., Hu, L., & Ruan, L. (2021) · Scientific Programming · doi:10.1155/2021/9959617 · Cited by 4 · see citing works

The Effects of Oral Administration of Deer Antler Extracts on an Osteoporosis-induced Animal Model: A Systematic Review and Meta-analysis

Lee, J. M., Kim, N. H., & Lee, D. W. (2022) · Journal of Korean Medicine Rehabilitation · doi:10.18325/jkmr.2022.32.2.65 · Cited by 3 · see citing works

Correlation between Body Composition and Bone Mineral Density Differs by Sex and Skeletal Site in Overweight and Obese Chinese Subjects

Chen, X., Guo, Y., Zhou, F., Wang, X., Wang, S., Zhang, C., Li, M., & Wu, Y. (2024) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2024.101526 · Cited by 2 · see citing works

Combined Effects of Romosozumab and Zoledronate on the Development of Osteonecrosis of the Jaw

Park, H.-S., Kim, S., An, S.-Y., Kim, R. H., Choi, J., & Kim, M. Y. (2026) · Oral Diseases · doi:10.1111/odi.70331 · Cited by 2 · see citing works

Indirect Decompression of Osteoporotic Vertebral Compression Fracture Using Intraoperative Motor Evoked Potential Monitoring-Guided Ligamentotaxis

Kweon, S., Kwon, S. M., Kim, C., Lee, C.-Y., Kim, I., & Ko, Y. S. (2023) · Korean Journal of Neurotrauma · doi:10.13004/kjnt.2023.19.e21 · Cited by 2 · see citing works

Does Zoledronic Acid Provide a Good Clinical Outcome in Patients With Chronic Back Pain Associated With Vertebral Osteoporosis?

Umesh, M., Ethiraj, P., Nazar, S. M., Agarawal, S. S., & Shanthappa, A. H. (2023) · Cureus · doi:10.7759/cureus.33328 · Cited by 2 · see citing works

Clinical research–When it matters

Yao, M., Wang, H., & Chen, W. (2022) · Injury · doi:10.1016/j.injury.2022.01.049 · Cited by 1 · see citing works

Progress in Prevention and Treatment of Acute Bone Loss in Orthopedics

Wang, H., Wu, J., Wang, B., Qin, H., Fan, L., Wang, Y.-H., & He, B. (2023) · International Journal of Endocrinology · doi:10.1155/2023/9373043 · Cited by 1 · see citing works

Monoclonal antibodies in patients with osteoporosis and renal insufficiency: An updated systematic review and meta-analysis

Defante, M. L. R., Alzogaray, V., Celso, D. S. G., Torres, L. A. F., Bearse, M., & Lopes, A. C. F. M. D. M. (2024) · Osteoporosis and Sarcopenia · doi:10.1016/j.afos.2024.05.004 · Cited by 1 · see citing works

Effects of Piper sarmentosum on Bone Health and Fracture Healing: A Scoping Review

Chin, K., Ekeuku, S. O., & Ramli, E. S. M. (2022) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530323666221130152737 · Cited by 1 · see citing works

The Effects of Switch Therapy in Osteoporosis Treatment after Romosozumab after Comparing with Prior Treatment

Horikawa, A., Kasukawa, Y., Hongo, M., Sano, A., & Miyakoshi, N. (2024) · Journal of Osteoporosis · doi:10.1155/2024/2144527 · Cited by 1 · see citing works

Bone-Muscle Crosstalk in Advanced Cancer and Chemotherapy

Waning, D. L. (2022) · Springer eBooks · doi:10.1007/978-3-031-09518-4_9 · Cited by 1 · see citing works

Detection of Branching in Trabecular Bone Using Multiscale COSFIRE Filter for Osteoporosis Identification

Wihandika, R. C., Arifin, A. Z., & Yuniarti, A. (2018) · International Conference on Frontiers of Educational Technologies (ICFET) · doi:10.1145/3233347.3233381

Impacto funcional de polimorfismos del gen de la esclerostina sobre la metilación de ADN y la expresión génica

del Real, Á., Sañudo, C., García‐Ibarbia, C., Santurtún, A., Zarrabeitia, M. T., Pérez‐Núñez, M. I., Laguna-Bercero, E., López-Delgado, L., Fernández, A. F., Fraga, M. F., et al. (2019) · Revista de Osteoporosis y Metabolismo Mineral · doi:10.4321/s1889-836x2019000400004

Is Romosozumab better than Teriparatide for the treatment of osteoporosis? A meta-analysis through a grade analysis of evidencePreprint

Liu, Z.-H., Ma, J., Sun, X., Zhang, S., Kuang, M., & Ma, X. (2019) · Research Square · doi:10.21203/rs.2.13598/v1

Pharmacological therapies for the prevention of fractures in men

Bråten, L. C. H., Johnston, R. V., Suter, C., Saku, S. A., Järvinen, T. L. N., & Buchbinder, R. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd014707

Current pharmacotherapy of osteoporosis and its future

Kukowka, A., Pluskota, M., Arciszewski, M., & Sroczyński, T. (2021) · Farmacja Polska · doi:10.32383/farmpol/145401

Condition still critical: compliance and persistence with osteoporosis medications

Gold, D. T. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813073-5.00072-1

Osteoporosis

Cochran, T., & Thacker, H. L. (2022) · Springer eBooks · doi:10.1007/978-3-030-99596-6_10

Antibodies as Therapeutic Agents

Rawat, R. S., & Kumar, S. (2023) · Springer eBooks · doi:10.1007/978-981-19-8249-1_5

Parathyroid Gland and Bone Therapies

Quarde, A. (2023) · doi:10.1002/9781119863564.ch5

Drugs associated with medication-related osteonecrosis of the jaw

Teoh, L., Moses, G., & McCullough, M. J. (2024) · Cambridge University Press eBooks · doi:10.1017/9781009057950.011

Production and Therapeutic Applications of Monoclonal Antibodies in Cancer and Other Diseases

Shahi, A., Patel, G. K., Kumar, S., Singh, M., Varshney, A., & Ghoshal, U. C. (2024) · doi:10.1002/9783527844340.ch26

In silico identification of sclerostin inhibitors

Şımşek, Y., Baran, S. S., Ergünol, E., Uludamar, A., Dinçel, A. S., & Erkoç, Ş. (2025) · Molecular Diversity · doi:10.1007/s11030-025-11298-0

Additional file 1 of Targeting SOST using a small-molecule compound retards breast cancer bone metastasis

Sun, L., Zhang, Y., Chen, G., Ji, Y., Ma, Q., Qiao, X., Wu, S., Zhou, L., Bu, J., Zhu, X., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26558123

ALKBH5/YTHDF2 Axis Regulates Osteogenic Differentiation Through Mediating the m 6 A Modification of ELK1

Yu, H., Ruan, T., & Peng, Y. (2026) · International Journal of Endocrinology · doi:10.1155/ije/2669506

Unveiling Hope: A Snapshot of CDSCO- Approved Monoclonal Antibodies in India

Bhardwaj, S., Chauhan, R. S., Tomar, A. S., Pachori, S., Mishra, H., Mourya, H., Sahu, T., & Garud, N. (2026) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2026.00208

Profile of romosozumab and its potential in the management of osteoporosis

Lim, S. Y., & Bolster, M. B. (2017) · DOAJ (DOAJ: Directory of Open Access Journals)

Pharmacological characteristics and clinical study results of romosozumab (EVENITY®; genetical recombination), a drug with novel mechanism of action to treat osteoporosis at high risk of fracture

Hamaya, E. (2020) · Folia Pharmacologica Japonica · doi:10.1254/fpj.20007 · Cited by 1 · see citing works

Romosozumab: from basic to clinical aspects

Minisola, S. (2014) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2014.920815 · Cited by 13 · see citing works

Treatment of osteoporosis

Paton, D. M. (2014)

Romosozumab: a novel bone anabolic treatment option for osteoporosis?

Kerschan‐Schindl, K. (2019) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-019-00721-5 · Cited by 35 · see citing works